These HIV Phase II trials have been designed in coordination with BP & Board of experts in the HIV field to obtain the data required. Any negotiations will be a continuation from extensive talks from prior results. Covid will be key to demonstrating broad spectrum direct acting antiviral activity in humans and may put a spanner in the works when it comes to prior extensive negotiations.
Also please name a Biotech on ASX who entitled to and not claiming R&D tax offset?
Results to Seal a Deal, page-91
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 968248 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 900263 | 3 |
View Market Depth
| Last trade - 16.12pm 08/10/2024 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable